- Associate Professor, Global Health
- Associate Professor, Biobehavioral Nursing and Health Informatics
- University of Washington Medical Center Endowed Professorship in Nursing Leadership, Biobehavioral Nursing and Health Informatics
Ninth and Jefferson Building Harborview Medical Center
325 9th Avenue (Box 359931)
Seattle, WA 98104
United States
Select from the following:
Dr. Jillian Pintye, RN, MPH, PhD is an Acting Assistant Professor in the Department of Global Health at the University of Washington. Her research focuses on HIV and STI prevention and treatment among young women, particularly within maternal child health settings. Dr. Pintye is the Principal Investigator of an NIH-funded R21 grant that evaluates in utero exposure of antiretroviral medications used during pregnancy among women living with HIV. She also leads data and laboratory operations for two large-scale implementation science studies on pre-exposure prophylaxis (PrEP) for HIV prevention. The PEPFAR/DREAMS-supported PrEP Implementation for Young Women and Adolescents (PrIYA) Program evaluates integrated PrEP delivery within routine antenatal, postnatal, and family planning clinics in Kisumu County, Kenya (PIs: Grace John-Stewart, Jared Baeten). The NIH-supported PrEP Implementation for Mothers in Antenatal Care (PrIMA) Study is a cluster-randomized trial in Homa Bay and Siaya, Kenya which evaluates the cost-effectiveness of risk-targeted and universal PrEP delivery approaches (PIs: Grace John-Stewart, Jared Baeten). Dr. Pintye was previously supported by an NIH F32 Fellowship to evaluate adherence to PrEP using biomarkers among pregnant and postpartum women in Western Kenya and was recently awarded a Center for AIDS Research (CFAR) New Investigator Award to expand her research on PrEP biomarkers for pregnant women. Prior to graduate school, Dr. Pintye was a Peace Corps Volunteer in Botswana, where she developed a passion for HIV prevention among women and children.
- BSN (La Salle University)
- MPH (University of Washington)
- PhD (University of Washington)
- Ikalanga
- Setswana
- Child and Adolescent Health (incl. Pediatrics)
- HIV/AIDS
- Maternal Child Health (incl. Reproductive Health)
- STDs (other than HIV)
1. J Pintye, JM Baeten, C Celum, N Mugo, K Ngure, E Were, EA Bukusi, G John-Stewart, RA Heffron. Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected East African women: a prospective study. Journal of Infectious Diseases (JID). 2017 Dec 19;216(12):1561-1568. PubMed PMID: 29040666; PMCID: PMC5853905
2. J Pintye, A Drake, J Kinuthia, JA. Unger, D Matemo, RA Heffron, RV Barnabas, P Kohler, R. Scott McClelland, G John-Stewart. A risk assessment tool for identifying pregnancy and postpartum women who may benefit from pre-exposure prophylaxis (PrEP). Clinical Infectious Diseases (CID). 2017 Mar 15;64(6):751-758. PubMed PMID:28034882; PMCID: PMC6075205
3. J Pintye, JM Baeten, L Manhart, C Celum, A Ronald, N Mugo, A Mujugira, C Cohen, E Were, E Bukusi, J Kiarie, RA Heffron, for the Partners PrEP Study Team. Decreased incidence of syphilis in both men and women associated with male circumcision: a prospective study among HIV-1 serodiscordant heterosexual African couples. The Lancet Global Health. 2014 Nov;2(11):e664-71. PubMed PMID: 25442691; PubMed Central PMCID: PMC4271270.
4. J Pintye, P Bacchetti, S Teeraananchai, S Kerr, W Prasitsuebsai, T Singtoroj, K Kuncze, A Louie, CA Koss, C Jin, N Phung, H Horng, AH Sohn, M Gandhi. Lopinavir Hair Concentrations are the Strongest Predictor of Viremia in HIV-infected Asian Children and Adolescents on Second-line Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes (JAIDS) 2017 Dec 1;76(4):367-371. PubMed PMID: 28825944; PubMed Central PMCID: PMC5659884.